Ledger.Open graph →
SEC Form D · filed March 12, 2024

ONL Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Ann Arbor, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David Zacks · Ann Arbor, MIExec · DirectorPalisade Partners, Inc · Englewood, CODirectorSampson L. Glassman · Winchester, VADirectorMiguel E. Prendens · Winchester, VADirectorStella Robertson · Ann Arbor, MIDirectorDavid Esposito · Ann Arbor, MIExec · DirectorGreg E. White · Fernandina Beach, FLExec · DirectorAri A. Santiago · Clayton, MODirectorMichael Turner · Winchester, VADirectorSean E. Foster · San Juan, Puerto RicoExec · DirectorHarold A. Thomas, Jr · Clayton, MOExecDavid Tingley · Naples, FLExec · DirectorSeth E. Roderick · Harrisonburg, VAExecMark Hooper · Ann Arbor, MIDirectorConstance Chang · Ann Arbor, MIExecMichael L. Appel · New York, NYDirectorBill Burns · Ann Arbor, MIDirectorJames L. Alt · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗